COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 1002: Articles 10011-10020  | Next

Interdependencies between cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M. M., Muensterkoetter, L., Schoen, M. P., Bergmann, A., Husar, T. M., Abratis, A., Eidizadeh, A., Schaffrinski, M., Zachmann, K., Schmitz, A., Holsapple, J. S., Stanisz-Bogeski, H., Schanz, J., Gross, U., Leha, A., Zautner, A. E., Schnelle, M., Erpenbeck, L.
10.1101/2021.12.13.21267729 — Posted: 2021-12-14
Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19
Shibata, Y., Minemura, H., Suzuki, Y., Nikaido, T., Tanino, Y., Fukuhara, A., Kanno, R., Saito, H., Suzuki, S., Ishii, T., Inokoshi, Y., Sando, E., Sakuma, H., Kobayashi, T., Kume, H., Kamimoto, M., Aoki, H., Takama, A., Kamiyama, T., Nakayama, M., Saito, K., Tanigawa, K., Sato, M., Kanbe, T., Kanzaki, N., Azuma, T., Sakamoto, K., Nakamura, Y., Otani, H., Waragai, M., Maeda, S., Ishida, T., Sugino, K., Inage, M., Hirama, N., Furuyama, K., Fukushima, S., Saito, H., Machiya, J.-i., Machida, H., Abe, K., Iwabuchi, K., Katagiri, Y., Aida, Y., Abe, Y., Ota, T., Ishizawa, Y., Tsukada, Y., Yamada, R., Sato, R., Omuna, T., Tomita, H., Saito, M., Watanabe, N., Rikimaru, M., Kawamata, T., Umeda, T., Morimoto, J., Togawa, R., Sato, Y., Saito, J., Kanazawa, K., Omae, K., Kurita, N., Iseki, K.
10.1101/2021.12.13.21267698 — Posted: 2021-12-14
Echinacea purpurea for the Long-term Prevention of Viral Respiratory Tract Infections during COVID-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study
Kolev, E., Mircheva, L., Edwards, M., Johnston, S. L., Kalinov, K., Stange, R., Gancitano, G., Vanden Berghe, W., Kreft, S.
10.1101/2021.12.10.21267582 — Posted: 2021-12-14
Safety and immunogenicity of a heterologous booster of protein subunit vaccine MVC-COV1901 after two doses of adenoviral vector vaccine AZD1222
Cheng, S.-H., Lin, Y.-C., Chen, C.-P., Cheng, C.-Y.
10.1101/2021.12.10.21267574 — Posted: 2021-12-14
The age-dependent immunogenicity after two doses of MVC-COV1901 vaccine.
Lien, C. E., Lin, Y.-J., Lin, Y.-L., Tai, I.-C., Chen, C.
10.1101/2021.12.12.21267573 — Posted: 2021-12-14
Modelling the recovery of elective waiting lists following COVID-19: scenario projections for England
Howlett, N. C., Wood, R. M.
10.1101/2021.12.13.21267732 — Posted: 2021-12-14
The impact of the COVID-19 school closure on adolescents' use of mental healthcare services in Sweden
Svaleryd, H. B., Bjorkegren, E., Vlachos, J.
10.1101/2021.12.12.21267684 — Posted: 2021-12-14
Vaccine breakthrough and the invasion dynamics of SARS-CoV-2 variants
Saad-Roy, C. M., Levin, S. A., Gog, J. R., Farrar, J., Wagner, C. E., Metcalf, C. J. E., Grenfell, B. T.
10.1101/2021.12.13.21267725 — Posted: 2021-12-14
Vaccination is reasonably effective in limiting the spread of COVID-19 infections, hospitalizations and deaths with COVID-19
Damijan, J. P., Damijan, S., Kostevc, C.
10.1101/2021.12.12.21267672 — Posted: 2021-12-14
Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study
Chou, O. H. I., Zhou, J., Lee, T. T. L., Kot, T., Lee, S., Wai, A. K. C., Wong, W. T., Zhang, Q., Cheng, S. H., Liu, T., Vassiliou, V. S., Cheung, B. M. Y., Tse, G.
10.1101/2021.12.13.21267730 — Posted: 2021-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).